S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities

Burning Rock Biotech (BNR) Competitors

GBX 0.84
+0.02 (+1.83%)
(As of 02/20/2024)

BNR vs. OVB, N4P, RENE, PYC, IDHC, NFX, FAB, DEMG, EVG, and IQAI

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Ovoca Bio (OVB), N4 Pharma (N4P), ReNeuron Group (RENE), Physiomics (PYC), Integrated Diagnostics (IDHC), Nuformix (NFX), Fusion Antibodies (FAB), Deltex Medical Group (DEMG), Evgen Pharma (EVG), and IQ-AI (IQAI). These companies are all part of the "medical" sector.

Burning Rock Biotech vs.

Ovoca Bio (LON:OVB) and Burning Rock Biotech (LON:BNR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 equaled Ovoca Bio'saverage media sentiment score.

Company Overall Sentiment
Ovoca Bio Neutral
Burning Rock Biotech Neutral

Ovoca Bio's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Ovoca BioN/A -33.98% -4.89%
Burning Rock Biotech N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ovoca Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ovoca BioN/AN/A-£2.33M-£0.02-43.75
Burning Rock BiotechN/AN/AN/AN/AN/A

Burning Rock Biotech received 48 more outperform votes than Ovoca Bio when rated by MarketBeat users. However, 70.83% of users gave Ovoca Bio an outperform vote while only 69.89% of users gave Burning Rock Biotech an outperform vote.

CompanyUnderperformOutperform
Ovoca BioOutperform Votes
17
70.83%
Underperform Votes
7
29.17%
Burning Rock BiotechOutperform Votes
65
69.89%
Underperform Votes
28
30.11%

Summary

Burning Rock Biotech beats Ovoca Bio on 3 of the 4 factors compared between the two stocks.


Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechDiagnostic Imaging Centers IndustryMedical SectorLON Exchange
Market Cap£883,000.00£883,000.00£4.96B£1.33B
Dividend YieldN/AN/A2.87%12.12%
P/E RatioN/AN/A175.961,701.28
Price / SalesN/AN/A2,876.85381,040.91
Price / CashN/AN/A32.6532.85
Price / BookN/AN/A4.482.50
Net IncomeN/AN/A£112.52M£178.60M
7 Day PerformanceN/AN/A1.16%0.30%
1 Month PerformanceN/AN/A12.60%0.59%
1 Year PerformanceN/AN/A13.07%28.48%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OVB
Ovoca Bio
0 of 5 stars
GBX 0.85
flat
N/AN/A£693,000.00N/A-42.505
N4P
N4 Pharma
0 of 5 stars
GBX 0.70
-3.3%
N/A-58.1%£1.88M£23,524.00-120.005Gap Down
RENE
ReNeuron Group
0 of 5 stars
GBX 3.38
-2.2%
N/A-69.3%£1.93M£783,000.00-37.5026Gap Down
PYC
Physiomics
0 of 5 stars
GBX 1.45
-3.3%
N/A-70.5%£1.96M£900,707.00-13.8310Gap Up
IDHC
Integrated Diagnostics
0 of 5 stars
GBX 0.33
-2.7%
N/A-16.2%£1.98M£3.86B16.506,718Gap Down
NFX
Nuformix
0 of 5 stars
GBX 0.27
-4.3%
N/A-43.4%£2.00M£50,000.00-1.633Gap Up
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.89
-0.2%
N/A-91.9%£2.32M£1.58M-43.2748
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.13
flat
N/AN/A£2.47M£2.38M-5.7544Gap Up
EVG
Evgen Pharma
0 of 5 stars
GBX 1
-9.1%
N/A-75.9%£2.75MN/A-100.0010
IQAI
IQ-AI
0 of 5 stars
GBX 1.80
+2.9%
N/A-45.4%£3.55M£538,190.00-13.676Gap Up

Related Companies and Tools

This page (LON:BNR) was last updated on 3/5/2024 by MarketBeat.com Staff